...
首页> 外文期刊>Journal of nephrology. >Kinetics of hepatitis C virus load during hemodialysis: novel perspectives.
【24h】

Kinetics of hepatitis C virus load during hemodialysis: novel perspectives.

机译:血液透析期间丙型肝炎病毒负荷的动力学:新观点。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hepatitis C virus (HCV) infection remains frequent among dialysis patients. The relationship between viral load and liver disease progression is currently a matter of debate; however, low HCV viral load (HCV RNA) is a well established predictor of successful antiviral treatment. Dialysis patients have immune compromise due to uremia; in spite of this, HCV viral load is not high and does not increase over time. A number of studies support the notion that this dynamics of HCV viral load may be related to lowering of HCV RNA titers during the HD procedure. It has been suggested that the intradialytic reduction of HCV is membrane-dependent; polysulphone (PS) and hemophan membranes appear more effective. Various mechanisms have been mentioned to explain the reduction of HCV RNA during hemodialysis (HD): adsorption of HCV onto dialysis membrane, HCV escape into spent dialysate, destruction of HCV particles or increased interferon (IFN) activity. Several investigators have noted that, at the end of the HD procedure, a virological rebound of HCV viremia occurs. Some suggestions have been made to minimize the risk for HCV escape into spent dialysate. However, controversial evidence on these issues exists: the HCV RNA reduction during HD procedures has not been seen in some studies and the relationship between the intra-dialytic reduction of HCV RNA titers and dialysis membrane is not completely understood. It is evident that additional long-term longitudinal studies by serial viral load estimations are needed to better define the dynamics of HCV viral load in the dialysis population.
机译:透析患者中​​丙型肝炎病毒(HCV)感染仍然很常见。病毒载量与肝病进展之间的关系目前尚在争论中。但是,低HCV病毒载量(HCV RNA)是成功抗病毒治疗的公认指标。透析患者由于尿毒症而免疫受损;尽管如此,HCV病毒载量并不高,并且不会随时间增加。大量研究支持以下观点:HCV病毒载量的这种动态变化可能与HD程序中HCV RNA滴度的降低有关。有人提出,透析中HCV的减少是膜依赖性的。聚砜(PS)和血色素膜似乎更有效。已经提到了多种机制来解释血液透析(HD)过程中HCV RNA的减少:HCV吸附在透析膜上,HCV逸出到废透析液中,HCV颗粒破坏或干扰素(IFN)活性增加。几位研究人员指出,在HD手术结束时,会发生HCV病毒血症的病毒学反弹。提出了一些建议以使HCV逸出到废透析液中的风险降到最低。但是,存在关于这些问题的有争议的证据:在一些研究中尚未发现HD手术期间HCV RNA的减少,并且对HCV RNA滴度的透析内减少与透析膜之间的关系尚未完全了解。显然,需要通过系列病毒载量估算进行其他长期纵向研究,以更好地定义透析人群中HCV病毒载量的动态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号